Thromboelastometric and platelet responses to silk biomaterials

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Hemocompatibility Studies

Background:

• Silk, a natural biopolymer, offers mechanical strength and fabrication versatility.
• Nonmulberry silks contain RGD sequences, enhancing cell adhesion for regenerative medicine applications.
• The blood compatibility of nonmulberry silk remains unevaluated, limiting its use in implants.

Purpose of the Study:

• To evaluate the hemocompatibility of Antheraea mylitta (nonmulberry) silk.
• To assess platelet interaction and blood coagulation following exposure to silk biomaterials.
• To compare nonmulberry silk's hemocompatibility with mulberry silk (Bombyx mori) and a clinical biomaterial (Uni-Graft W).

Main Methods:

• Thromboelastometry (ROTEM) was employed to analyze blood coagulation.
• Platelet activation and interaction with silk biomaterials were investigated.
• Comparative analysis was performed against Bombyx mori silk and Uni-Graft W.

Main Results:

• Tested silk biomaterials demonstrated shortened clotting and clot formation times.
• Enhanced clot strength indicated significant platelet-mediated activation of the coagulation cascade.
• Hemocompatibility results were comparable to both mulberry silk and the clinical control.

Conclusions:

• Antheraea mylitta silk exhibits favorable hemocompatibility, comparable to Bombyx mori silk and Uni-Graft W.
• The observed platelet activation suggests potential for silk-based biomaterials in medical implants.
• Further research into silk biomaterials is warranted for regenerative medicine and implant applications.